- Report
- May 2023
- 526 Pages
Global
From €3800EUR$4,175USD£3,228GBP
- Report
- August 2023
- 133 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- September 2022
- 86 Pages
Global
From €3500EUR$4,119USD£3,077GBP
- Report
- October 2023
- 146 Pages
Global
From €3211EUR$3,528USD£2,727GBP
€3777EUR$4,150USD£3,208GBP
- Report
- February 2022
- 80 Pages
Africa
From €1820EUR$2,000USD£1,546GBP
- Report
- February 2022
- 40 Pages
Brazil
From €1365EUR$1,500USD£1,160GBP
- Report
- February 2022
- 40 Pages
China
From €1365EUR$1,500USD£1,160GBP
- Report
- February 2022
- 40 Pages
France
From €1365EUR$1,500USD£1,160GBP
- Report
- February 2022
- 40 Pages
Germany
From €1365EUR$1,500USD£1,160GBP
- Report
- February 2022
- 40 Pages
Ireland
From €1365EUR$1,500USD£1,160GBP
- Report
- February 2022
- 40 Pages
Japan
From €1365EUR$1,500USD£1,160GBP
- Report
- February 2022
- 40 Pages
Russia
From €1365EUR$1,500USD£1,160GBP
- Report
- February 2022
- 40 Pages
South Korea
From €1365EUR$1,500USD£1,160GBP
- Report
- February 2022
- 40 Pages
United States
From €1365EUR$1,500USD£1,160GBP
- Report
- February 2022
- 40 Pages
Vietnam
From €1365EUR$1,500USD£1,160GBP
- Report
- March 2024
- 132 Pages
Global
From €865EUR$950USD£734GBP
- Report
- March 2024
- 132 Pages
Global
From €865EUR$950USD£734GBP
- Report
- May 2023
- 132 Pages
Global
From €865EUR$950USD£734GBP
- Report
- November 2021
- 1112 Pages
Global
From €5461EUR$6,000USD£4,638GBP
- Report
- October 2023
- 272 Pages
Global
From €2275EUR$2,499USD£1,932GBP
€3249EUR$3,570USD£2,760GBP

The Nucleic Acid Amplification (NAA) market within the In Vitro Diagnostics (IVD) industry is a rapidly growing segment. NAA is a technique used to detect and quantify nucleic acids, such as DNA and RNA, from a variety of sources. It is used in a wide range of applications, including clinical diagnostics, food safety testing, and environmental monitoring. NAA is a highly sensitive and specific method for detecting and quantifying nucleic acids, and is increasingly being used in IVD applications.
NAA technology is used in a variety of IVD tests, including infectious disease testing, genetic testing, and cancer diagnostics. It is also used in the development of new diagnostic tests, such as those for emerging infectious diseases. NAA technology is also being used in the development of personalized medicine, allowing for the detection of genetic mutations that may be associated with certain diseases.
The NAA market is expected to continue to grow in the coming years, driven by the increasing demand for IVD tests and the development of new technologies. Major players in the NAA market include Roche Diagnostics, Abbott Laboratories, Becton Dickinson, Qiagen, and Thermo Fisher Scientific. Show Less Read more